RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. ProJenX

ProJenX

ProJenX's mission is to make prosetin, a scientifically validated, first-in-class MAP4 kinase inhibitor, available for ALS and other neurodegenerative diseases.

Latest funding

Series A ·

Amount not disclosed in a source on record.

Funding history ↓
Website: projenx.com.
Category: Health and bio.
Stage: Series A.
Last round: Nov 2, 2023 · 1,110 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredAug 12, 2021 (5 years old)

Funding rounds

DateRoundAmountLeadSource
Series Aundisclosed—fundraisingfox.com

Timeline

  1. Website created

Founders and team

Companies like ProJenX

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/projenx (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy